LabCompass

Hong Boon Lee

Engineering · Indiana University

OpenAlex ORCID
Established · publishing since 1972
Nanoplatforms for cancer theranosticsPhotodynamic Therapy Research StudiesNanoparticle-Based Drug DeliveryPorphyrin and Phthalocyanine ChemistryLuminescence and Fluorescent Materials

Publications

96

Citations

5,108

Est. group size

—

Recurring co-author estimate

Active years

55

Publishing since 1972

Research summary
AI-generated

Hong Boon Lee works at the intersection of nanotechnology and cancer treatment, designing tiny particle-based systems (such as gold nanoparticles, dendrimers, and polymer carriers) that deliver drugs or light-activated agents to tumors. Much of the work focuses on photodynamic and photothermal therapy, where light-sensitive molecules are used to destroy cancer cells, along with assessing the safety of these nanoscale materials in the body.

Nanoparticle-based cancer drug deliveryPhotodynamic and photothermal therapyLight-activated photosensitizers (BODIPY, porphyrins, phthalocyanines)Targeted anticancer therapeutics and conjugatesSafety and toxicology of nanomaterials

Publication activity was highest around 2017-2018 and has slowed to roughly one paper per year in recent years, with none recorded in 2023-2024.

Generated by claude-opus-4-8 from public bibliographic data · Jul 9, 2026

Funding
Public award records

Current awards run through August 2028 — about 2 years of funding on record from today. Awards are often renewed, so this is what is currently public, not a forecast.

  • ActiveNSF 2552966through Aug 2028 · $199k awarded

    ERI: Advanced Forecasting of Coastal Flooding and Extreme Rainfall

Matched to public NIH RePORTER and NSF records by name and institution. Awards from other agencies are not shown, and a match is not always found — this list may be incomplete.

In context
Among 1,566 established Engineering PIs within our index
Citations: 5,108cohort median 1,768
h-index: 31cohort median 21
Publications / year (recent): 1.0cohort median 4.2

Typically publishes in teams of ~9 · 3% small-team papers (≤3 authors) · across 27 venues

Publication cadence
Publications per year over the last 10 years — averaging 1.0/year recently
2017: 7 publications7172018: 4 publications182019: 1 publication192020: 2 publications202021: 3 publications212022: 3 publications2223242025: 1 publication252026: 1 publication26
Collaborators per year
Distinct co-authors at Indiana University each year — a rough indication of whether the group around this researcher has been growing or contracting. An estimate from co-authorship, not a roster: collaborators are not necessarily lab members, and recent years can be under-counted while indexing catches up.
2017: 0 collaborators at the same institution2018: 0 collaborators at the same institution2019: 0 collaborators at the same institution2020: 0 collaborators at the same institution2021: 0 collaborators at the same institution2022: 0 collaborators at the same institution2023: 0 collaborators at the same institution2024: 0 collaborators at the same institution2025: 1 collaborator at the same institution1719212325
Recent publications
Publishes in
  • International Journal of Pharmaceutics×3
  • The Cambridge Structural Database×3
  • Macromolecular Bioscience×2
  • SSRN Electronic Journal×2
  • Journal of Controlled Release×1
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 27, 2026.

Claim or correct this profile